Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Evaluating the Effectiveness of an AI-Powered Physician Assistant in Improving Patients' and Physicians' Satisfaction in Anaesthesiology Clinics

31 luglio 2026 aggiornato da: Dileep Kumar, Aga Khan University

Evaluating the Effectiveness of an AI-Powered Physician Assistant in Improving Patients' and Physicians' Satisfaction in Anaesthesiology Clinics of a Tertiary Care Hospital

This trial aimed to evaluate the effectiveness of an AI-Powered Physician Assistant in improving patients' satisfaction with the quality of care. It also aims to evaluate physicians' satisfaction with the integration of a Physician Assistant into their clinical workflows. The primary research question is

A. What is the effect of an AI-powered Physician Assistant on patients' satisfaction with their quality of care compared to the standard care?

The secondary questions are as follows:

B1. How satisfied are physicians with integrating an AI-powered physician assistant into their daily clinical workflows?

B2. Which factors are significantly associated with patient satisfaction regarding the AI-Powered Physician Assistant?

B3. Is there a statistically significant difference in mean consultation time per patient between those receiving AI-assisted care and those receiving only standard of careonly ?

Participants will be enrolled from pre-operative outpatient clinics, including patients attending clinic for anaesthetic clearance prior to surgery and consultant anaesthetists providing care.

Patients will serve as the unit of randomization and will be assigned to one of two study arms on each clinic day. On each clinic day, the first 8 eligible patients presenting for consultation will be randomly assigned to the intervention group or the control group in a 1:1 ratio. Intervention patients will proceed to a dedicated waiting room for structured digital intake via an AI platform (demographics, symptoms, history, clinical data) and receive AI-assisted care. Control group patients will undergo routine standard care protocols. The consultant physician will evaluate both arms during each clinic session, reviewing physician assistant-generated patient summaries and charts for patients in both the intervention and control groups.

Each patient will be asked to fill out the survey at the end of the consultation with the physician. The consultants will be requested to fill out a survey at the end of the day.

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Stimato)

180

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Sindh
      • Karachi, Sindh, Pakistan, 74800
        • Aga Khan University Hospital
        • Contatto:
        • Contatto:
        • Investigatore principale:
          • Dileep Kumar

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Descrizione

Patients and Patients' Proxies

Inclusion Criteria:

  • Consent to participate
  • Age 18 years and above
  • Initial patients
  • Possession of a phone
  • Read and write Urdu and/or English

Exclusion Criteria:

  • Emergency Care patients
  • Follow-up patients

Physicians:

Inclusion Criteria

  • Attending or Consultant Physician
  • Consent to participate
  • Workflow integrated with AI Assistant

Exclusion Criteria

- Residents and Senior Medical Officers

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: AI-Assisted Care
The patients in this arm will receive AI-assisted care in addition to the standard care. The AI platform will take the patient's history, and then the patient will talk to the consultant as part of the routine flow.
The study participant allocated to the intervention arm will interact with the AI-physician assistant application before they consult with the physician. The application will collect medical history of the patient. This will then be followed by an AI-generated clinical summary, which their physicians will receive before the consultation begins. Physicians will review this summary and ask further questions of patients if required. Any additions and changes in the patient's history will also be made. Physicians will subsequently conduct a physical examination of the patient. After this, the physician will be able to view AI- and guideline-based suggestions for the patient's assessment and pre-operative management. The recommendations can be selected, modified, or not used as per the physician's expertise. All additions within the application can be either typed manually or verbalised via an AI-assisted scribe within the application.
Nessun intervento: Standard Care
The patients in this arm will receive standard care. The standard of care for our study is what is usually applied in Anaesthesiology outpatient clinics, with consultants seeing the patients after the resident.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Patient Satisfaction and Outpatient Experience Score (Adapted NHS Outpatient Survey - Patient Questionnaire)
Lasso di tempo: From enrollment to the end of the study, for each patient, for 8 weeks

Patient satisfaction will be evaluated across two domains: (1) effective utilization of waiting time and (2) receipt of patient-centered care during the outpatient visit.

Evaluated post-consultation using a structured survey adapted from the NHS Outpatient Survey: Section A (Wait Time): Wait duration (A1) and wait time utility (A2). Section B (Doctor Interaction): Patient-centered care, consultation duration, listening, and clarity (B2-B7). Section C (AI Assistant - Intervention Arm Only): Perceived listening, trust, and privacy (C1-C6). Section D (Overall Impression): Respect, dignity, and care- quality (D1-D3).

Ordinal items are assigned numerical scores to calculate a composite mean score and domain sub-scores (range: 1.0-5.0). Higher scores indicate greater satisfaction.

From enrollment to the end of the study, for each patient, for 8 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Daily Physician Satisfaction and Workflow Efficiency Score (End-of-Day Physician Survey)
Lasso di tempo: From enrollment to the end of the study, for each physician, for 8 weeks

Physician satisfaction and workflow efficiency will be evaluated using an end-of-day survey administered to physicians whose patients were recruited into the study. Evaluated using a two-part structured questionnaire:

Section 1 (Comparative Workflow): Binary comparisons across 5 domains (consultation duration, patient engagement, documentation efficiency, cognitive workload, and focus on patient care), with 3-point follow-up sub-questions for favorable intervention responses.

Section 2 (Intervention Utility): 6 intervention-specific items assessing accuracy/trust, workflow efficiency, workload relief, and overall satisfaction (5-point ordinal scales; 1 = Strongly Disagree, 5 = Strongly Agree).

Daily composite mean scores are calculated from Sections 1 and 2 (range: 1.0-5.0). Higher scores indicate greater satisfaction.

From enrollment to the end of the study, for each physician, for 8 weeks
Total Physician Consultation Duration (Stopwatch Timestamps)
Lasso di tempo: From enrollment to the end of the study, for each patient, for 8 weeks

Evaluates total physician consultation duration (in minutes) for each patient during their outpatient clinic encounter.

Consultation time refers to the active time spent by the physician while the patient is inside the consultation room. It encompasses the time taken to inquire about symptoms, conduct physical examinations, prescribe treatments, and provide counseling.

Duration is objectively measured in minutes using manual stopwatch timestamps, initiated the moment the patient enters the consultation room and concluded when the patient departs.

Mean total consultation times will be calculated per patient and compared between the intervention and standard care arms. Lower or more optimized consultation durations reflect enhanced workflow efficiency.

From enrollment to the end of the study, for each patient, for 8 weeks

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Process flow evaluation outcome - Mean Queuing Time (Timestamp Tracking)
Lasso di tempo: From enrollment to the end of the study, for each patient, for 8 weeks

Recorded using objective timestamps across two sequential intervals:

Interval 1: Completion of counter registration to initiation of vital signs measurement.

Interval 2: Completion of vital signs measurement to patient entry into the physician consultation room.

Intervals are combined into a single aggregated total queuing time per patient visit. Lower mean queuing times indicate improved operational workflow efficiency.

From enrollment to the end of the study, for each patient, for 8 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Dileep Kumar, Aga Khan University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

30 agosto 2026

Completamento primario (Stimato)

30 ottobre 2026

Completamento dello studio (Stimato)

30 ottobre 2026

Date di iscrizione allo studio

Primo inviato

28 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

31 luglio 2026

Primo Inserito (Effettivo)

3 agosto 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

3 agosto 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

31 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

The plan is to publish the study, and informed consent has been obtained from each participant. Each participant's data will be de-identified at the source level for both the application and survey.

Criteri di accesso alla condivisione IPD

Through Publication Only

Tipo di informazioni di supporto alla condivisione IPD

  • LINFA
  • RSI

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi